Ignyte Platform Inc. dba Ignyte Assurance Platform
5818 Wilmington Pike, #220, 45459, Centerville, OH, United States
Visit website- Scope lines
- 2
- A2LA certificate
- 1
- Site in our directory
- 1
What this lab is accredited for
We could not match the method references in this lab’s scope to published test standard numbers. The full scope as published is below.
Only this lab. Searches the method, matrix and range of each of the 2 scope lines.
A2LA certificate 6081.01 · 2 lines
| Line | Method | Matrix | Range |
|---|---|---|---|
| 1 | ISO/IEC 17020:2012; NIST 800 series special publications | Cloud Products and Services | - |
| 2 | Extracted from the scope document; tables may not line up. View scope for the original. For the inspections to which this accreditation applies, please refer to the organization’s Inspection Body Scope of Accreditation.
Accredited Inspection Body
A2LA has accredited
IGNYTE ASSURANCE PLATFORM
Centerville, OH
for technical competence in and compliance with the
Inspection Body Accreditation Program
This inspection body is accredited in accordance with the recognized International Standard
ISO/IEC 17020:2012 Conformity Assessment – Requirements for the operation of various types of bodies
performing inspection. This accreditation demonstrates technical competence for a defined scope and
the operation of a quality management system.
Presented this 15th day of April 2025.
__ _____________________
Mr. Trace McInturff, Vice President, Accreditation Services
For the Accreditation Council
Certificate Number 6081.01
Valid to May 31, 2027 | ||
Ranges are reproduced from the accredited scope document as published, and only where we found that range printed in the document for the line. Otherwise the cell reads “See scope document”. An absent range means the register did not state one. Line numbers are ours, for cross-reference; they follow the order of the scope document.
Location
Accreditation data refreshed from the A2LA register on .
This page mirrors a public register. For a purchasing, audit or regulatory decision, confirm against the A2LA entry linked above.